SlideShare une entreprise Scribd logo
1  sur  38
Spirometry of ObstructiveLung Diseases
Pulmonary Disorders Effects onPulmonary Function 
Obstructive: 
Any process that interferes with air flow either into or out of the lungs. 
Large or small airways. 
Restrictive: 
Any process that interferes with the bellows action of the lungs or chest wall. 
Reduced lung volumes.
Differential Diagnosis: COPD and Asthma 
COPD 
Onset In mid-life 
Symptoms slowly progressive 
Long smoking history 
Dyspnea during exercise 
Largely Irreversible airflow limitation 
Asthma 
Onset early in life (often childhood) 
Symptoms vary from day to day 
Symptoms at nigh/early morning 
Allergy, rhinitis, and/or eczema also present 
Family history of asthma 
Largely reversible airflow limitation
Inflammatory Cascade inCOPD & Asthma
Measures of Assessment andMonitoring of Asthma 
Asthma diagnosis criteria: 
Positive episodic symptoms of airflow obstruction. 
Airflow obstruction partially reversible. 
R/ O alternative dx.
Objective lung functionmeasurements in Asthma 
Spirometry: 
▫Forced Expiratory Maneuvers. 
Exhaled Nitric Oxide. 
Peak Flows.
EPR-3 Statements for Asthma 
The Expert Panel recommends that office-based physicians who care for asthma patients should have access to spirometry, which is useful in both diagnosis and periodic monitoring . 
Spirometryshould be performed using equipment and techniques that meet standards developed by the ATS (EPR-2 1997).
GOLD 2013: Diagnosis of COPD 
SPIROMETRY REQUIREDTO DIAGNOSE COPD 
Presence of a post-bronchodilator FEV1/FVC < 0.70 confirms the presence of persistent airflow limitation and thus of COPD. 
Key Indicators to Consider COPD Diagnosis: 
1 
•SYMPTOMS 
•Dyspnea-progressive (worsens over time and with exercise) 
•Chronic cough 
•Sputum 
2 
•HISTORY OF EXPOSURE TO RISK FACTORS 
•Tobacco smoke 
•Smoke from home cooking/heating fuels 
•Occupational dusts and chemical 
3 
•FAMILY HISTORY OF COPD 
Adapted from GOLD 2013
Spirometry 
Spirometryshould be performed after the administration of an adequate dose of a short acting inhaled bronchodilator (e.g. 400 ᶙg salbutamol) to minimize variability. 
A post-bronchodilator FEV 1/FVC <0.70 confirms the presence of airflow limitation that is not fully reversible. 
Where possible, values should be compared to age-related normal values to avoid over- diagnosis of COPD In the elderly.
Why Do We Need Spirometryin COPD? 
Spirometryis useful for: 
Screen individuals at risk for pulmonary disease. 
Confirmation of COPD diagnosis. 
Assessing severity of pulmonary dysfunction. 
Guiding selection of treatment. 
Assessing the effects of therapeutic interventions.
Who Should Be Screened forCOPD? 
Consider COPD, and perform spirometry, if any of these indicators are present in an individual over age 40. 
▫Dyspnea that is progressive, usually worse with exercise, and persistent. 
▫Chronic cough (may be intermittent and unproductive). 
▫Chronic sputum. 
▫History of tobacco smoke exposure. 
▫Exposure to occupational dusts and chemicals. 
▫Risk factors. 
▫Exposure to smoke from home cooking and heating fuels.
SpirometryOrigin 
Most basic of Pulmonary Function Tests 
Clinical Tools Origin -Mid 1800' s 
▫John Hutchinson. 
▫Water-sealed spirometryto measure vital capacity (VC).
Reasons for PerformingSpirometry 
Diagnostic Purposes. 
Monitoring Lung Disease. 
Assessing Disability.
Spirometry 
Spirometrywith flow volume loops assesses the mechanical properties of the respiratory system by measuring expiratory volumes and flow rates. 
▫Maximal inspiratory and expiratory effort. 
▫At least 3 tests of acceptable effort are performed to ensure reproducibility.
21st Century Spirometry 
Measurements of: 
Forced Vital Capacity (FVC). 
Forced Expiratory Volume in one second (FEV1). 
Forced Expiratory Volume in six seconds (FEV6). 
Forced Expiratory Flow over various Intervals (FEFx). 
Peak Expiratory Flow (PEF).
Definitions and Terms 
FEV1 -forced expiratory volume 1 -the volume of air that is forcefully exhaled in one second. 
FEV6 -forced expiratory volume 6 -the volume of air that Is forcefully exhaled in six seconds. 
FVC-forced vital capacity-the volume of air that can be maximally forcefully exhaled. 
FEV/FVC-ratio of FEV1 to FVC, expressed as a percentage.
Definitions and Terms 
FEV/FVC-ratio of FEV6 to FVC, expressed as a percentage. 
FEF25 -75 -forced expiratory flow -the average forced expiratory flow during the mid (25 -75%) portion of the FVC. 
PEF-peak expiratory flow rate -the peak flow rate during expiration.
Spirometry 
Flow volume loops provide a graphic illustration of a patient's spirometricefforts. 
Flow is plotted against volume to display a continuous loop from inspiration to expiration. 
The volume versus time curve is a an alternative way of plotting spirometricresults. 
The overall shape of the flow volume loop is important in Interpreting spirometricresults.
Acceptability & Repeatability
Acceptability 
At least three (3) acceptable maneuvers 
Good start to the test. 
No hesitation or coughing for the 1stsecond. 
FVC lasts at least 6 seconds with a plateau of at least 1 second. 
No valsalvamaneuver or obstruction of the mouthpiece. 
FIVC shows apparent maximal effort.
Repeatability 
Repeatability criteria act as guideline to determine need for additional efforts. 
▫Largest and 2nd largest FVC must be within 150 mL. 
▫Largest and 2nd largest FEV 1 must be 150 mL. 
▫PEF values may be variable (within 15%). 
If three acceptable reproducible maneuvers are not recorded, up to B attempts may be recorded.
SpirometryValue 
Spirometryis typically reported in both absolute values and as a predicted percentage of normal. 
Normal values vary and are dependent on: 
▫Gender, 
▫Race, 
▫Age, and 
▫Height.
Reporting Standards 
Largest FVC obtained from all acceptable efforts should be reported. 
Largest FEV1 obtained from all acceptable trials should be reported. 
May or may not come from largest FVC effort. 
All other flows, should come from the effort with the largest sum of FEV 1 & FVC. 
PEF should be the largest value obtained from at least 3 acceptable maneuvers.
Results ReportingExample
Report Format 
Report should also include: 
▫Age on testing day. 
▫Height (standing without shoes). 
▫Weight (without shoes). 
▫Gender. 
▫Race or ethnic origin. 
▫Technologist comment section.
FEV1 Results for Asthma
FEV 1 Severity Results for Asthma
At Risk for COPD 
Spirometricclassification of airflow limitation (in patients with FEV1/FVC<0.70). 
▫GOLD 1(Mild; FEV1 ≥80% predicted). 
▫GOLD 2 (Moderate; 50% ≤FEV1 <80% predicted). 
▫GOLD 3 (Severe; 30% ≤FEV1 <50% predicted). 
▫GOLD 4 (Very severe; FEV1 <30% predicted). 
Adapted from GOLD 2013
Pre & Post BronchodilatorStudies 
B-Adrenergic aerosols are most common form for testing. 
Standardize. 
▫Drug. 
▫Dosage. 
▫Delivery Device. 
Minimum of 15 minutes between pre and post tests.
Pre & Post Bronchodilator Studies: Withholding Medications
Pre & Post BronchodilatorStudies: Interpretations 
Determined based on improvement of FEV1. 
Commonly expressed as Percent Change. 
% Change = Post FEV 1 -Pre FEV1 x 100 
Pre FEV1
Reversibility 
Reversibility of airways obstruction can be assessed with the use of bronchodilators. 
> 12% increase in the FEV1 and 200 ml 
improvement in FEV1 
OR 
> 12% increase in the FVC and 200 ml 
improvement in FVC.
Spirometry
Asthma Challenge Testing 
Spirometrycan be used to detect the bronchial hyperreactivitythat characterizes asthma. 
Increasing concentrations of histamine or methacholine. 
Patients with asthma will demonstrate symptoms and produce spirometricresults consistent with airways obstruction at much lower threshold concentration than normals.
Bronchial Provocation for Asthma
Other Diagnostic Tests 
Sputum Induction 
6-Minute Walks 
Impulse Oscillometry 
Exhaled Nitric Oxide 
Exhaled Breath Condensate
References
COPD Lecture 9  spirometry of obstructive lung diseases

Contenu connexe

Tendances (20)

Asthma biomarkers: FENO
Asthma biomarkers: FENOAsthma biomarkers: FENO
Asthma biomarkers: FENO
 
Defence mechanism of lung
Defence mechanism of lungDefence mechanism of lung
Defence mechanism of lung
 
History taking
History takingHistory taking
History taking
 
Spirometry
SpirometrySpirometry
Spirometry
 
Ventilation and perfusion
Ventilation and perfusionVentilation and perfusion
Ventilation and perfusion
 
10.Pneumothorax
10.Pneumothorax10.Pneumothorax
10.Pneumothorax
 
Respiratory failure
Respiratory failureRespiratory failure
Respiratory failure
 
Breathlessness
BreathlessnessBreathlessness
Breathlessness
 
Asthma Basics
Asthma BasicsAsthma Basics
Asthma Basics
 
Pulmonary auscultation
Pulmonary auscultationPulmonary auscultation
Pulmonary auscultation
 
Reactive airway diseases_2018_pmm
Reactive airway diseases_2018_pmmReactive airway diseases_2018_pmm
Reactive airway diseases_2018_pmm
 
Acute severe Asthma case presentation
Acute severe Asthma case presentationAcute severe Asthma case presentation
Acute severe Asthma case presentation
 
Pneumothorax.pptx
Pneumothorax.pptxPneumothorax.pptx
Pneumothorax.pptx
 
Diagnosing pleural effusion
Diagnosing pleural effusionDiagnosing pleural effusion
Diagnosing pleural effusion
 
Approach to Lung sounds
Approach to Lung soundsApproach to Lung sounds
Approach to Lung sounds
 
Lights criteria pleural diseases
Lights criteria  pleural diseasesLights criteria  pleural diseases
Lights criteria pleural diseases
 
Airway and ventilation management
Airway and ventilation managementAirway and ventilation management
Airway and ventilation management
 
Evaluation of preoperative pulmonary risk
Evaluation of preoperative pulmonary riskEvaluation of preoperative pulmonary risk
Evaluation of preoperative pulmonary risk
 
Lung volume reduction surgery
Lung volume reduction surgeryLung volume reduction surgery
Lung volume reduction surgery
 
ARDS - Diagnosis and Management
ARDS - Diagnosis and ManagementARDS - Diagnosis and Management
ARDS - Diagnosis and Management
 

En vedette

Obstructive vs. Restrictive Lung disease
Obstructive vs.  Restrictive Lung diseaseObstructive vs.  Restrictive Lung disease
Obstructive vs. Restrictive Lung diseaseFatima Awadh
 
obstructive & restrictive lung disease
obstructive & restrictive lung diseaseobstructive & restrictive lung disease
obstructive & restrictive lung diseasedrghaida
 
Diagnosis and Assessment of copd
Diagnosis and Assessment of copdDiagnosis and Assessment of copd
Diagnosis and Assessment of copdAshraf ElAdawy
 
COPD Lecture 7 Medication adherence in chronic obstructive lung diseases
COPD Lecture 7   Medication adherence in chronic obstructive lung diseasesCOPD Lecture 7   Medication adherence in chronic obstructive lung diseases
COPD Lecture 7 Medication adherence in chronic obstructive lung diseasesDr.Mahmoud Abbas
 
Home Spirometry: Assessment of patient's compliance and satisfaction and its ...
Home Spirometry: Assessment of patient's compliance and satisfaction and its ...Home Spirometry: Assessment of patient's compliance and satisfaction and its ...
Home Spirometry: Assessment of patient's compliance and satisfaction and its ...Apollo Hospitals Group and ATNF
 
Spirometry workshop
Spirometry workshopSpirometry workshop
Spirometry workshoptaito0209
 
Expiratory flow limitation_diseases
Expiratory flow limitation_diseasesExpiratory flow limitation_diseases
Expiratory flow limitation_diseasesUbaidur Rahaman
 
Bronchial Asthma
Bronchial AsthmaBronchial Asthma
Bronchial Asthmacairo1957
 
Hyponatremia management pearls 1
Hyponatremia management pearls 1Hyponatremia management pearls 1
Hyponatremia management pearls 1Ubaidur Rahaman
 
Asthma vs COPD - A quick summary of the differences between them
Asthma vs COPD - A quick summary of the differences between themAsthma vs COPD - A quick summary of the differences between them
Asthma vs COPD - A quick summary of the differences between themLGM Pharma
 
Mechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and AsthmaMechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and AsthmaDr.Mahmoud Abbas
 
Mapleson breathing systems
Mapleson breathing systemsMapleson breathing systems
Mapleson breathing systemsgaganbrar18
 
Compliance Resistance & Work Of Breathing
Compliance Resistance & Work Of Breathing  Compliance Resistance & Work Of Breathing
Compliance Resistance & Work Of Breathing Zareer Tafadar
 

En vedette (20)

Obstructive vs. Restrictive Lung disease
Obstructive vs.  Restrictive Lung diseaseObstructive vs.  Restrictive Lung disease
Obstructive vs. Restrictive Lung disease
 
obstructive & restrictive lung disease
obstructive & restrictive lung diseaseobstructive & restrictive lung disease
obstructive & restrictive lung disease
 
Diagnosis and Assessment of copd
Diagnosis and Assessment of copdDiagnosis and Assessment of copd
Diagnosis and Assessment of copd
 
COPD Lecture 7 Medication adherence in chronic obstructive lung diseases
COPD Lecture 7   Medication adherence in chronic obstructive lung diseasesCOPD Lecture 7   Medication adherence in chronic obstructive lung diseases
COPD Lecture 7 Medication adherence in chronic obstructive lung diseases
 
Home Spirometry: Assessment of patient's compliance and satisfaction and its ...
Home Spirometry: Assessment of patient's compliance and satisfaction and its ...Home Spirometry: Assessment of patient's compliance and satisfaction and its ...
Home Spirometry: Assessment of patient's compliance and satisfaction and its ...
 
Spirometry workshop
Spirometry workshopSpirometry workshop
Spirometry workshop
 
Expiratory flow limitation_diseases
Expiratory flow limitation_diseasesExpiratory flow limitation_diseases
Expiratory flow limitation_diseases
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Bronchial Asthma
Bronchial AsthmaBronchial Asthma
Bronchial Asthma
 
Spirometry
SpirometrySpirometry
Spirometry
 
ACUTE GI BLEEDING
 ACUTE GI BLEEDING ACUTE GI BLEEDING
ACUTE GI BLEEDING
 
Hyponatremia management pearls 1
Hyponatremia management pearls 1Hyponatremia management pearls 1
Hyponatremia management pearls 1
 
Asthma vs COPD - A quick summary of the differences between them
Asthma vs COPD - A quick summary of the differences between themAsthma vs COPD - A quick summary of the differences between them
Asthma vs COPD - A quick summary of the differences between them
 
Mechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and AsthmaMechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and Asthma
 
Spirometry
SpirometrySpirometry
Spirometry
 
Spirometry Basics
Spirometry BasicsSpirometry Basics
Spirometry Basics
 
Mapleson breathing systems
Mapleson breathing systemsMapleson breathing systems
Mapleson breathing systems
 
COPD GOLD 2014
COPD GOLD 2014COPD GOLD 2014
COPD GOLD 2014
 
Compliance Resistance & Work Of Breathing
Compliance Resistance & Work Of Breathing  Compliance Resistance & Work Of Breathing
Compliance Resistance & Work Of Breathing
 
Colloid vs Crystalloids
Colloid vs CrystalloidsColloid vs Crystalloids
Colloid vs Crystalloids
 

Similaire à COPD Lecture 9 spirometry of obstructive lung diseases

Anaecon India - Spirometery
Anaecon India - SpirometeryAnaecon India - Spirometery
Anaecon India - SpirometerySarthak Jain
 
Diagnosis of COPD
Diagnosis of COPDDiagnosis of COPD
Diagnosis of COPDGamal Agmy
 
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONPULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONLincyAsha
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function testraghu srikanti
 
Spirometry by dr tasleem
Spirometry by dr tasleemSpirometry by dr tasleem
Spirometry by dr tasleemTASLEEM ARIF
 
COPD Session 2
COPD Session 2COPD Session 2
COPD Session 2Gamal Agmy
 
Lung volumes and capacities.pptx
Lung volumes and capacities.pptxLung volumes and capacities.pptx
Lung volumes and capacities.pptxManoj Aryal
 
Bedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFTBedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFTZIKRULLAH MALLICK
 
Interpretation of Clinical Lab Data [PFTs] for Newbies.pdf
Interpretation of Clinical Lab Data [PFTs] for Newbies.pdfInterpretation of Clinical Lab Data [PFTs] for Newbies.pdf
Interpretation of Clinical Lab Data [PFTs] for Newbies.pdfsamthamby79
 
Updates in Diagnosis of COPD
Updates in Diagnosis of COPDUpdates in Diagnosis of COPD
Updates in Diagnosis of COPDGamal Agmy
 
PULMONARY FUNCTION TEST.pptx
PULMONARY FUNCTION TEST.pptxPULMONARY FUNCTION TEST.pptx
PULMONARY FUNCTION TEST.pptxAmeena Kadar
 
Common pulmonary functions and interpretation
Common pulmonary functions and interpretationCommon pulmonary functions and interpretation
Common pulmonary functions and interpretationSubhajit Ghosh
 
Lung function tests
Lung function testsLung function tests
Lung function testsdeka dada
 

Similaire à COPD Lecture 9 spirometry of obstructive lung diseases (20)

Anaecon India - Spirometery
Anaecon India - SpirometeryAnaecon India - Spirometery
Anaecon India - Spirometery
 
Diagnosis of COPD
Diagnosis of COPDDiagnosis of COPD
Diagnosis of COPD
 
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONPULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
 
Spirometry
 Spirometry Spirometry
Spirometry
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function test
 
Spirometry by dr tasleem
Spirometry by dr tasleemSpirometry by dr tasleem
Spirometry by dr tasleem
 
COPD Session 2
COPD Session 2COPD Session 2
COPD Session 2
 
Lung volumes and capacities.pptx
Lung volumes and capacities.pptxLung volumes and capacities.pptx
Lung volumes and capacities.pptx
 
Bedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFTBedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFT
 
Interpretation of Clinical Lab Data [PFTs] for Newbies.pdf
Interpretation of Clinical Lab Data [PFTs] for Newbies.pdfInterpretation of Clinical Lab Data [PFTs] for Newbies.pdf
Interpretation of Clinical Lab Data [PFTs] for Newbies.pdf
 
Updates in Diagnosis of COPD
Updates in Diagnosis of COPDUpdates in Diagnosis of COPD
Updates in Diagnosis of COPD
 
Pulmonary function testing
Pulmonary function testingPulmonary function testing
Pulmonary function testing
 
PFT.pptx
PFT.pptxPFT.pptx
PFT.pptx
 
PFT
PFT PFT
PFT
 
Lung fuction tests
Lung fuction tests  Lung fuction tests
Lung fuction tests
 
PULMONARY FUNCTION TEST.pptx
PULMONARY FUNCTION TEST.pptxPULMONARY FUNCTION TEST.pptx
PULMONARY FUNCTION TEST.pptx
 
Pocket Guide to Lung Function Tests - sample chapter
Pocket Guide to Lung Function Tests - sample chapterPocket Guide to Lung Function Tests - sample chapter
Pocket Guide to Lung Function Tests - sample chapter
 
Common pulmonary functions and interpretation
Common pulmonary functions and interpretationCommon pulmonary functions and interpretation
Common pulmonary functions and interpretation
 
Bedside pft 1
Bedside pft 1Bedside pft 1
Bedside pft 1
 
Lung function tests
Lung function testsLung function tests
Lung function tests
 

Plus de Dr.Mahmoud Abbas

EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer ZahanaEGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer ZahanaDr.Mahmoud Abbas
 
Technologies for the Fashion Industry_ What’s new_ (1).pdf
Technologies for the Fashion Industry_ What’s new_  (1).pdfTechnologies for the Fashion Industry_ What’s new_  (1).pdf
Technologies for the Fashion Industry_ What’s new_ (1).pdfDr.Mahmoud Abbas
 
Natural Dyes Greener ways to color textiles.pdf
Natural Dyes Greener ways to color textiles.pdfNatural Dyes Greener ways to color textiles.pdf
Natural Dyes Greener ways to color textiles.pdfDr.Mahmoud Abbas
 
Trends in Active wear and Athleisure.pdf
Trends in Active wear and Athleisure.pdfTrends in Active wear and Athleisure.pdf
Trends in Active wear and Athleisure.pdfDr.Mahmoud Abbas
 
The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...
The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...
The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...Dr.Mahmoud Abbas
 
Drug Induced Kidney Injury in the ICU.pdf
Drug Induced Kidney Injury in the ICU.pdfDrug Induced Kidney Injury in the ICU.pdf
Drug Induced Kidney Injury in the ICU.pdfDr.Mahmoud Abbas
 
Using Novel Kidney Biomarkers to Guide Drug Therapy.pdf
Using Novel Kidney Biomarkers to Guide Drug Therapy.pdfUsing Novel Kidney Biomarkers to Guide Drug Therapy.pdf
Using Novel Kidney Biomarkers to Guide Drug Therapy.pdfDr.Mahmoud Abbas
 
How Textile Digital Printing Changed Interior Designs.pdf
How Textile Digital Printing Changed Interior Designs.pdfHow Textile Digital Printing Changed Interior Designs.pdf
How Textile Digital Printing Changed Interior Designs.pdfDr.Mahmoud Abbas
 
What makes a design fashionable (prints & fashion).pdf
What makes a design fashionable (prints & fashion).pdfWhat makes a design fashionable (prints & fashion).pdf
What makes a design fashionable (prints & fashion).pdfDr.Mahmoud Abbas
 
Use of Steroids in COVID 19- Egyptian Critical Care Summit.pdf
Use of Steroids in COVID 19- Egyptian Critical Care Summit.pdfUse of Steroids in COVID 19- Egyptian Critical Care Summit.pdf
Use of Steroids in COVID 19- Egyptian Critical Care Summit.pdfDr.Mahmoud Abbas
 
Decorative effects on wool fabrics.pdf
Decorative effects on wool fabrics.pdfDecorative effects on wool fabrics.pdf
Decorative effects on wool fabrics.pdfDr.Mahmoud Abbas
 
Technical textiles the future of textile
Technical textiles the future of textileTechnical textiles the future of textile
Technical textiles the future of textileDr.Mahmoud Abbas
 
The future of the jeans sustainable washing cairo textile week
The future of the jeans sustainable washing cairo textile weekThe future of the jeans sustainable washing cairo textile week
The future of the jeans sustainable washing cairo textile weekDr.Mahmoud Abbas
 
Why Egypt should be competitive in the Global Denim Supply Chain?
Why Egypt should be competitive in the Global Denim Supply Chain?Why Egypt should be competitive in the Global Denim Supply Chain?
Why Egypt should be competitive in the Global Denim Supply Chain?Dr.Mahmoud Abbas
 
Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...
Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...
Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...Dr.Mahmoud Abbas
 
Non operative management of blunt abdominal trauma
Non operative management of blunt abdominal traumaNon operative management of blunt abdominal trauma
Non operative management of blunt abdominal traumaDr.Mahmoud Abbas
 
History of critical care center cairo university
History of critical care center cairo universityHistory of critical care center cairo university
History of critical care center cairo universityDr.Mahmoud Abbas
 
Kemet presentation itex cairo 2021
Kemet presentation itex cairo 2021 Kemet presentation itex cairo 2021
Kemet presentation itex cairo 2021 Dr.Mahmoud Abbas
 
Incorporating printed fabrics in interior decoration and acoustic panels
Incorporating printed fabrics in interior decoration and acoustic panelsIncorporating printed fabrics in interior decoration and acoustic panels
Incorporating printed fabrics in interior decoration and acoustic panelsDr.Mahmoud Abbas
 
How digital printing is adding value to active wear and athleisure?
How digital printing is adding value to active wear and athleisure?How digital printing is adding value to active wear and athleisure?
How digital printing is adding value to active wear and athleisure?Dr.Mahmoud Abbas
 

Plus de Dr.Mahmoud Abbas (20)

EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer ZahanaEGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
 
Technologies for the Fashion Industry_ What’s new_ (1).pdf
Technologies for the Fashion Industry_ What’s new_  (1).pdfTechnologies for the Fashion Industry_ What’s new_  (1).pdf
Technologies for the Fashion Industry_ What’s new_ (1).pdf
 
Natural Dyes Greener ways to color textiles.pdf
Natural Dyes Greener ways to color textiles.pdfNatural Dyes Greener ways to color textiles.pdf
Natural Dyes Greener ways to color textiles.pdf
 
Trends in Active wear and Athleisure.pdf
Trends in Active wear and Athleisure.pdfTrends in Active wear and Athleisure.pdf
Trends in Active wear and Athleisure.pdf
 
The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...
The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...
The Changing Role of the Coronary Care Cardiologist & The Emerging Role of Ca...
 
Drug Induced Kidney Injury in the ICU.pdf
Drug Induced Kidney Injury in the ICU.pdfDrug Induced Kidney Injury in the ICU.pdf
Drug Induced Kidney Injury in the ICU.pdf
 
Using Novel Kidney Biomarkers to Guide Drug Therapy.pdf
Using Novel Kidney Biomarkers to Guide Drug Therapy.pdfUsing Novel Kidney Biomarkers to Guide Drug Therapy.pdf
Using Novel Kidney Biomarkers to Guide Drug Therapy.pdf
 
How Textile Digital Printing Changed Interior Designs.pdf
How Textile Digital Printing Changed Interior Designs.pdfHow Textile Digital Printing Changed Interior Designs.pdf
How Textile Digital Printing Changed Interior Designs.pdf
 
What makes a design fashionable (prints & fashion).pdf
What makes a design fashionable (prints & fashion).pdfWhat makes a design fashionable (prints & fashion).pdf
What makes a design fashionable (prints & fashion).pdf
 
Use of Steroids in COVID 19- Egyptian Critical Care Summit.pdf
Use of Steroids in COVID 19- Egyptian Critical Care Summit.pdfUse of Steroids in COVID 19- Egyptian Critical Care Summit.pdf
Use of Steroids in COVID 19- Egyptian Critical Care Summit.pdf
 
Decorative effects on wool fabrics.pdf
Decorative effects on wool fabrics.pdfDecorative effects on wool fabrics.pdf
Decorative effects on wool fabrics.pdf
 
Technical textiles the future of textile
Technical textiles the future of textileTechnical textiles the future of textile
Technical textiles the future of textile
 
The future of the jeans sustainable washing cairo textile week
The future of the jeans sustainable washing cairo textile weekThe future of the jeans sustainable washing cairo textile week
The future of the jeans sustainable washing cairo textile week
 
Why Egypt should be competitive in the Global Denim Supply Chain?
Why Egypt should be competitive in the Global Denim Supply Chain?Why Egypt should be competitive in the Global Denim Supply Chain?
Why Egypt should be competitive in the Global Denim Supply Chain?
 
Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...
Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...
Cairo Textile Week 2021 Conference -Egypt Textiles & Home Textiles Export Cou...
 
Non operative management of blunt abdominal trauma
Non operative management of blunt abdominal traumaNon operative management of blunt abdominal trauma
Non operative management of blunt abdominal trauma
 
History of critical care center cairo university
History of critical care center cairo universityHistory of critical care center cairo university
History of critical care center cairo university
 
Kemet presentation itex cairo 2021
Kemet presentation itex cairo 2021 Kemet presentation itex cairo 2021
Kemet presentation itex cairo 2021
 
Incorporating printed fabrics in interior decoration and acoustic panels
Incorporating printed fabrics in interior decoration and acoustic panelsIncorporating printed fabrics in interior decoration and acoustic panels
Incorporating printed fabrics in interior decoration and acoustic panels
 
How digital printing is adding value to active wear and athleisure?
How digital printing is adding value to active wear and athleisure?How digital printing is adding value to active wear and athleisure?
How digital printing is adding value to active wear and athleisure?
 

COPD Lecture 9 spirometry of obstructive lung diseases

  • 2. Pulmonary Disorders Effects onPulmonary Function Obstructive: Any process that interferes with air flow either into or out of the lungs. Large or small airways. Restrictive: Any process that interferes with the bellows action of the lungs or chest wall. Reduced lung volumes.
  • 3. Differential Diagnosis: COPD and Asthma COPD Onset In mid-life Symptoms slowly progressive Long smoking history Dyspnea during exercise Largely Irreversible airflow limitation Asthma Onset early in life (often childhood) Symptoms vary from day to day Symptoms at nigh/early morning Allergy, rhinitis, and/or eczema also present Family history of asthma Largely reversible airflow limitation
  • 5. Measures of Assessment andMonitoring of Asthma Asthma diagnosis criteria: Positive episodic symptoms of airflow obstruction. Airflow obstruction partially reversible. R/ O alternative dx.
  • 6. Objective lung functionmeasurements in Asthma Spirometry: ▫Forced Expiratory Maneuvers. Exhaled Nitric Oxide. Peak Flows.
  • 7. EPR-3 Statements for Asthma The Expert Panel recommends that office-based physicians who care for asthma patients should have access to spirometry, which is useful in both diagnosis and periodic monitoring . Spirometryshould be performed using equipment and techniques that meet standards developed by the ATS (EPR-2 1997).
  • 8. GOLD 2013: Diagnosis of COPD SPIROMETRY REQUIREDTO DIAGNOSE COPD Presence of a post-bronchodilator FEV1/FVC < 0.70 confirms the presence of persistent airflow limitation and thus of COPD. Key Indicators to Consider COPD Diagnosis: 1 •SYMPTOMS •Dyspnea-progressive (worsens over time and with exercise) •Chronic cough •Sputum 2 •HISTORY OF EXPOSURE TO RISK FACTORS •Tobacco smoke •Smoke from home cooking/heating fuels •Occupational dusts and chemical 3 •FAMILY HISTORY OF COPD Adapted from GOLD 2013
  • 9. Spirometry Spirometryshould be performed after the administration of an adequate dose of a short acting inhaled bronchodilator (e.g. 400 ᶙg salbutamol) to minimize variability. A post-bronchodilator FEV 1/FVC <0.70 confirms the presence of airflow limitation that is not fully reversible. Where possible, values should be compared to age-related normal values to avoid over- diagnosis of COPD In the elderly.
  • 10. Why Do We Need Spirometryin COPD? Spirometryis useful for: Screen individuals at risk for pulmonary disease. Confirmation of COPD diagnosis. Assessing severity of pulmonary dysfunction. Guiding selection of treatment. Assessing the effects of therapeutic interventions.
  • 11. Who Should Be Screened forCOPD? Consider COPD, and perform spirometry, if any of these indicators are present in an individual over age 40. ▫Dyspnea that is progressive, usually worse with exercise, and persistent. ▫Chronic cough (may be intermittent and unproductive). ▫Chronic sputum. ▫History of tobacco smoke exposure. ▫Exposure to occupational dusts and chemicals. ▫Risk factors. ▫Exposure to smoke from home cooking and heating fuels.
  • 12. SpirometryOrigin Most basic of Pulmonary Function Tests Clinical Tools Origin -Mid 1800' s ▫John Hutchinson. ▫Water-sealed spirometryto measure vital capacity (VC).
  • 13. Reasons for PerformingSpirometry Diagnostic Purposes. Monitoring Lung Disease. Assessing Disability.
  • 14. Spirometry Spirometrywith flow volume loops assesses the mechanical properties of the respiratory system by measuring expiratory volumes and flow rates. ▫Maximal inspiratory and expiratory effort. ▫At least 3 tests of acceptable effort are performed to ensure reproducibility.
  • 15. 21st Century Spirometry Measurements of: Forced Vital Capacity (FVC). Forced Expiratory Volume in one second (FEV1). Forced Expiratory Volume in six seconds (FEV6). Forced Expiratory Flow over various Intervals (FEFx). Peak Expiratory Flow (PEF).
  • 16. Definitions and Terms FEV1 -forced expiratory volume 1 -the volume of air that is forcefully exhaled in one second. FEV6 -forced expiratory volume 6 -the volume of air that Is forcefully exhaled in six seconds. FVC-forced vital capacity-the volume of air that can be maximally forcefully exhaled. FEV/FVC-ratio of FEV1 to FVC, expressed as a percentage.
  • 17. Definitions and Terms FEV/FVC-ratio of FEV6 to FVC, expressed as a percentage. FEF25 -75 -forced expiratory flow -the average forced expiratory flow during the mid (25 -75%) portion of the FVC. PEF-peak expiratory flow rate -the peak flow rate during expiration.
  • 18. Spirometry Flow volume loops provide a graphic illustration of a patient's spirometricefforts. Flow is plotted against volume to display a continuous loop from inspiration to expiration. The volume versus time curve is a an alternative way of plotting spirometricresults. The overall shape of the flow volume loop is important in Interpreting spirometricresults.
  • 20. Acceptability At least three (3) acceptable maneuvers Good start to the test. No hesitation or coughing for the 1stsecond. FVC lasts at least 6 seconds with a plateau of at least 1 second. No valsalvamaneuver or obstruction of the mouthpiece. FIVC shows apparent maximal effort.
  • 21. Repeatability Repeatability criteria act as guideline to determine need for additional efforts. ▫Largest and 2nd largest FVC must be within 150 mL. ▫Largest and 2nd largest FEV 1 must be 150 mL. ▫PEF values may be variable (within 15%). If three acceptable reproducible maneuvers are not recorded, up to B attempts may be recorded.
  • 22. SpirometryValue Spirometryis typically reported in both absolute values and as a predicted percentage of normal. Normal values vary and are dependent on: ▫Gender, ▫Race, ▫Age, and ▫Height.
  • 23. Reporting Standards Largest FVC obtained from all acceptable efforts should be reported. Largest FEV1 obtained from all acceptable trials should be reported. May or may not come from largest FVC effort. All other flows, should come from the effort with the largest sum of FEV 1 & FVC. PEF should be the largest value obtained from at least 3 acceptable maneuvers.
  • 25. Report Format Report should also include: ▫Age on testing day. ▫Height (standing without shoes). ▫Weight (without shoes). ▫Gender. ▫Race or ethnic origin. ▫Technologist comment section.
  • 27. FEV 1 Severity Results for Asthma
  • 28. At Risk for COPD Spirometricclassification of airflow limitation (in patients with FEV1/FVC<0.70). ▫GOLD 1(Mild; FEV1 ≥80% predicted). ▫GOLD 2 (Moderate; 50% ≤FEV1 <80% predicted). ▫GOLD 3 (Severe; 30% ≤FEV1 <50% predicted). ▫GOLD 4 (Very severe; FEV1 <30% predicted). Adapted from GOLD 2013
  • 29. Pre & Post BronchodilatorStudies B-Adrenergic aerosols are most common form for testing. Standardize. ▫Drug. ▫Dosage. ▫Delivery Device. Minimum of 15 minutes between pre and post tests.
  • 30. Pre & Post Bronchodilator Studies: Withholding Medications
  • 31. Pre & Post BronchodilatorStudies: Interpretations Determined based on improvement of FEV1. Commonly expressed as Percent Change. % Change = Post FEV 1 -Pre FEV1 x 100 Pre FEV1
  • 32. Reversibility Reversibility of airways obstruction can be assessed with the use of bronchodilators. > 12% increase in the FEV1 and 200 ml improvement in FEV1 OR > 12% increase in the FVC and 200 ml improvement in FVC.
  • 34. Asthma Challenge Testing Spirometrycan be used to detect the bronchial hyperreactivitythat characterizes asthma. Increasing concentrations of histamine or methacholine. Patients with asthma will demonstrate symptoms and produce spirometricresults consistent with airways obstruction at much lower threshold concentration than normals.
  • 36. Other Diagnostic Tests Sputum Induction 6-Minute Walks Impulse Oscillometry Exhaled Nitric Oxide Exhaled Breath Condensate